Psychedelics
Company will collaborate with Premier Consulting as regulatory partner and utilize Zylö Therapeutics Z-Pod technology
Hi, what are you looking for?
Mugglehead Investment Magazine
Research
Research
DMT is the backbone structure of popular psychedelics being tested for medical purposes such as psilocin and LSD
Cannabis
New study also suggests that plant-derived medicines can reduce inflammation and improve mental health
Cannabis
UK Cannabis Center will investigate the potential of the plant for treating medical conditions
Cannabis
Market growth will be driven by a variety of factors
Psychedelics
New study will compare the effects of MDA and MDMA in humans for the first time
Research
Increasing rates of stress, insomnia and other sleep disorders around the globe will propel market growth
Business
Legalization of cannabis in multiple countries such as the U.S., Canada and Australia will be primary driver of market growth
Canada
Study will evaluate psilocybin efficacy in healthcare workers with mental health challenges related to pandemic
Research
Recent demand for sleep devices is partially attributed to rising rates of anxiety disorders in American population
